136 Results
Guidelines and Advice
Status: Current
ID: GL 26-2
Version: 3
ID: GL 26-2
Version: 3
Mar 2021
Guidelines and Advice
Status: Current
ID: GL 27-2
Version: 2
ID: GL 27-2
Version: 2
Feb 2021
Guidelines and Advice
Status: Current
ID: GL END 5-7
Version: 3
ID: GL END 5-7
Version: 3
Nov 2021
Guidelines and Advice
Status: Current
ID: GL 4-1
Version: 2
ID: GL 4-1
Version: 2
Jan 2021
Guidelines and Advice
Status: Current
ID: GL-C50-10
Version: 1
ID: GL-C50-10
Version: 1
May 2021
Guidelines and Advice
Status: Current
ID: 3-14
Version: 3
ID: 3-14
Version: 3
Updated
Jun 2025
Guidelines and Advice
Status: Current
ID: GL MOTAC-4
Version: 3
ID: GL MOTAC-4
Version: 3
Updated
Jun 2025
Guidelines and Advice
Status: Current
ID: GL-C50-27
ID: GL-C50-27
Nov 2021
Guidelines and Advice
Status: Current
ID: GL-C50-32
ID: GL-C50-32
Jan 2021
Drug
Jun 2025
Drug
Mar 2021
Drug
Other Name(s): Rituxan®
, Truxima™
, Riximyo™
, Ruxience™
, Riabni™
Jun 2025
